Eliane Abou-Jaoude
Allergy & Immunology · Washington, DCNPI 1053730655
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $42,378 of the $65,754 with a category attached, or 64.4%. Sanofi accounts for 87.9% of it on its own, with 29 other manufacturers making up the rest. 2025 is the largest year on record at $54,427, more than ten times the $182 reported in 2019.
Across 413 payments — averaging $159.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$58K
- AstraZeneca$3K
- GSK$1K
- Regeneron Healthcare Solutions, Inc.$711
- Amgen$631
- Pfizer$452
- plus $2K from 24 others
What the payments were for
- Consulting fees$8,36413%
- Speaking & faculty fees$42,37864%
- Travel & lodging$2,3504%
- Food & beverage$12,60319%
- Education$600%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 116 | $57,823 |
| AstraZeneca | 71 | $2,952 |
| GSK | 75 | $1,166 |
| Regeneron Healthcare Solutions, Inc. | 26 | $711 |
| Amgen | 22 | $631 |
| Pfizer | 13 | $452 |
| CSL Behring | 12 | $263 |
| ARS Pharmaceuticals Operations, Inc. | 10 | $214 |
| Kaleo, Inc. | 8 | $204 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $192 |
| Genentech USA, Inc. | 7 | $180 |
| Optinose US, Inc. | 8 | $142 |
| Biocryst US Sales Co., LLC | 5 | $116 |
| Novartis | 4 | $97 |
| Hikma Pharmaceuticals USA | 4 | $84 |
| Pharming Healthcare, Inc. | 4 | $83 |
| Teva Pharmaceuticals USA, Inc. | 3 | $57 |
| Blueprint Medicines Corporation | 2 | $45 |
| Incyte Corporation | 2 | $45 |
| AbbVie | 2 | $40 |
| Boehringer Ingelheim | 2 | $38 |
| Aimmune Therapeutics, Inc. | 2 | $36 |
| Ionis Pharmaceuticals, Inc. | 1 | $30 |
| Phadia US Inc. | 1 | $27 |
| Greer Laboratories, Inc. | 1 | $25 |
| Dermavant Sciences, Inc. | 1 | $25 |
| LEO Pharma Inc. | 1 | $22 |
| Organon | 1 | $22 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Mylan Specialty L.p. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$65,754 in reported general payments places this provider in the 85th percentile of 20 allergy & immunology providers in District of Columbia.
See all allergy & immunology providers in District of Columbia →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Montelukast Sodium | 14 | $323 |
Paid to pharmacies, not to this prescriber.
Other allergy & immunology in Washington
- Autumn BurnetteWashington$2.3M
- Lawrence DubuskeWashington$1.8M
- Daniel EinWashington$52K
- Olabunmi AgboolaWashington$13K
- Dan BrodyWashington$9K
- Michael KellerWashington$9K
- Maribel Mamonluk-ChuaWashington$7K
- Sebastian Ochoa GonzalezWashington$6K
- Janine van LanckerWashington$4K
- Sana HabibWashington$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.